Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Irbesartan und Hydrochlorothiazid (ATC: C09DA24)
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Irbesartan und Hydrochlorothiazid (ATC: C09DA24)
Don't miss the next one like this
New health grants in DEU open all the time. Get a free weekly email with only the ones that match — nothing else.
Want help winning this?
Enter your email and we'll send the official application link, deadlines and pointers right away — free. Want a hand? Tick the box and we'll introduce you to a vetted grant or bid writer. The intro's free, and you only pay if you choose to work with them.
Related opportunities
See all alternatives →Germany – Pharmaceutical products – 61. Generika-Ausschreibung
→Germany – Pharmaceutical products – 61. Generika-Ausschreibung
TenderCloses 2026-09-21DEUHealthGermany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Vilanterol und Umeclidiniumbromid (ATC: R03AL03)
→Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Vilanterol und Umeclidiniumbromid (ATC: R03AL03)
TenderCloses 2028-07-31DEUHealthGermany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
→Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
TenderCloses 2028-07-05DEUHealthGermany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens
→Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens
TenderCloses 2028-08-05DEUHealthGermany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Entecavir (ATC: J05AF10 - in der Darreichungsform Filmtabletten)
→Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Entecavir (ATC: J05AF10 - in der Darreichungsform Filmtabletten)
TenderCloses 2028-07-31DEUHealthSSbD bio-based alternatives for fertilising and/or crop protection products
→Expected Outcome: Successful proposals will contribute to the updated EU Bioeconomy Strategy, Farm to Fork Strategy, the Horizon Europe Mission ‘A Soil Deal for Europe’, in particular the objectives: ‘Reduce soil pollution and enhance restoration’, the European Chemical Industry Action Plan as well as the Clean Industrial Deal. Projects results are expected to contribute to the following expected outcomes: Full industrial scale biorefinery and related value chain(s) for the sustainable production of bio-based fertilisers and/or crop protection solutions. Increased availability of cost-competitive and SSbD bio-based alternatives for fertilising and/or crop protection products with suitable agronomic efficacy. Reduced reliance on synthetic/mineral agricultural chemical products. Increased EU strategic autonomy, resilience and competitiveness through a robust cooperation among bio-based industries and farmers. Increased soil health, including minimising accumulation of microplastics and pollutants in soil and water, with positive effects on quality, security and resilience of food production in agriculture. Scope: FAO estimates that up to 40% of food crops are lost due to plant pests…
Grant$22.8MCloses 2026-09-22EUHealth
Always confirm details on the official source before applying — see our methodology.